Uri Elia

Israel Institute for Biological Research — Israel

Medicine · Health Sciences

14h-index837citations44works2.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

SARS-CoV-2 and COVID-19 Research(16), Bacillus and Francisella bacterial research(14), Bacteriophages and microbial interactions(8), Animal Virus Infections Studies(7), RNA Interference and Gene Delivery(6)

Publications44 total

A symphony of immunity: How HPV mRNA-LNP vaccination orchestrates systemic anti-tumor responses
Molecular Therapy — Nucleic Acids·2026Open Access
The mRNA component of LNP-mRNA vaccines triggers IFNAR-dependent immune activation which attenuates the adaptive immune response
Frontiers in Immunology·2025· 3 citedOpen Access
Challenges and opportunities in mRNA vaccine development against bacteria
Nature Microbiology·2025· 6 citedOpen Access
Novel Bivalent mRNA‐LNP Vaccine for Highly Effective Protection against Pneumonic Plague (Adv. Sci. 26/2025)
Advanced Science·2025Open Access
On‐Chip De Novo Production of mRNA Vaccine in Lipid Nanoparticles
Small·2025· 3 citedOpen Access
Novel Bivalent mRNA‐LNP Vaccine for Highly Effective Protection against Pneumonic Plague
Advanced Science·2025· 4 citedOpen Access
A Novel Virulent Clinical Isolate of Burkholderia pseudomallei Imported from Thailand Exhibiting Resistance to Trimethoprim-Sulfamethoxazole
American Journal of Tropical Medicine and Hygiene·2024· 1 citedOpen Access
Genome sequence of two novel virulent clinical strains of Burkholderia pseudomallei isolated from acute melioidosis cases imported to Israel from India and Thailand
BMC Genomic Data·2024· 2 citedOpen Access
Immunogenicity of a Third Dose of BNT162b2 Vaccine among Lung Transplant Recipients—A Prospective Cohort Study
Vaccines·2023· 2 citedOpen Access
CRISPR editing in the lung with novel lipids
Nature Biotechnology·2023· 5 citedOpen Access
A single-dose F1-based mRNA-LNP vaccine provides protection against the lethal plague bacterium
Science Advances·2023· 86 citedOpen Access
A Novel Approach to Vaccine Development: Concomitant Pathogen Inactivation and Host Immune Stimulation by Peroxynitrite
Vaccines·2022· 5 citedOpen Access
An Effective mRNA-LNP Vaccine Against the Lethal Plague Bacterium
2022· 2 citedOpen Access
Humoral and T-Cell Response before and after a Fourth BNT162b2 Vaccine Dose in Adults ≥60 Years
Journal of Clinical Medicine·2022· 8 citedOpen Access
Genome-wide CRISPR screens identify GATA6 as a proviral host factor for SARS-CoV-2 via modulation of ACE2
Nature Communications·2022· 48 citedOpen Access
Immune Response to Third Dose BNT162b2 COVID-19 Vaccine Among Kidney Transplant Recipients—A Prospective Study
Transplant International·2022· 28 citedOpen Access
T Cell Response following Anti-COVID-19 BNT162b2 Vaccination Is Maintained against the SARS-CoV-2 Omicron B.1.1.529 Variant of Concern
Viruses·2022· 15 citedOpen Access
T cell response following anti COVID-19 BNT162b2 vaccination is maintained against the SARS-CoV-2 Omicron B.1.1.529 variant of concern
2022· 7 citedOpen Access
Preliminary nonclinical safety and immunogenicity of an rVSV-ΔG-SARS-CoV-2-S vaccine in mice, hamsters, rabbits and pigs
Archives of Toxicology·2022· 12 citedOpen Access
Cellular Immune Responses to BNT162b2 mRNA COVID-19 Vaccine in Patients with Chronic Lymphocytic Leukemia
Blood·2021· 4 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Erez Bar‐Haim(30), Ofer Cohen(30), Shahar Rotem(25), Theodor Chitlaru(22), Hagai Cohen(21), Ma’ayan Israeli(17), Moshe Aftalion(13), Dan Peer(12), Ofir Israeli(10), Inbar Cohen-Gihon(10), Adi Beth-Din(10), Emanuelle Mamroud(8), Adi Bercovich-Kinori(8), Anat Zvi(8), Shirley Lazar(8), David Gur(7), Gonna Somu Naidu(6), Tomer Israely(6), Edo Kon(5), Efi Makdasi(5)